The aim of this study is to evaluate the effects of sildenafil citrate on cisplatin-induced ovarian toxicity. Thirty-two female rats were divided into four groups. Group 1: saline control; group 2: cisplatin; group 3: sildenafil citrate; and group 4: cisplatin plus sildenafil citrate group. In groups 2 and 4, the rats were injected with 5 mg/kg cisplatin intraperitoneally (i.p.). In groups 3 and 4, the rats were injected with 1.4 mg/kg sildenafil citrate i.p. The ovaries were removed two weeks later in all groups. Histopathologic examination, follicle counting and classification were performed. The expression of anti-Mullerian hormone (AMH) was detected immunohistochemically in the ovarian tissues. Sildenafil alleviated cisplatin-induced hi...
The aim of the present study was to evaluate the protective effect of gallic acid (GA) against cispl...
OBJECTIVE: To determine the effect of cyclophosphamide and cisplatin on ovarian reserve in rats by t...
Background: Cisplatin is a potent antineoplastic agent for many cancers but causes several levels of...
The aim of this study is to evaluate the effects of sildenafil citrate on cisplatin-induced ovarian ...
Introduction: Agents to reduce the gonadotoxic effects of chemotherapeutics are still under investig...
Purpose: This study was aimed to evaluate the protective effect of edaravone on cisplatin-induced ov...
Aim: This study investigated the protective effects of sildenafil (SIL) and resveratrol (RSV) on ova...
WOS: 000343022600014PubMed ID: 25142624Objective: To investigate whether granulocyte-colony stimulat...
Objective: To evaluate the protective effect of GnRH agonist for the prevention of ovarian reserve d...
Background. Apart from the role of progesterone in reproductive physiology, the protective role of e...
PubMed ID: 24959584Cisplatin (CP), an antitumor agent, has been shown to cause ovarian injury and dy...
Sildenafil is the first commercially available selective inhibitor of phosphodiesterase-5 (PDE5) and...
The aim of this study was to investigate the potential therapeutic efficacy of chrysin (CHS) against...
Ovarian damage and fertility impairment are major side effects of chemotherapy in pre-menopausal can...
Copyright © 2014 Oytun Erbas ̧ et al. This is an open access article distributed under the Creative ...
The aim of the present study was to evaluate the protective effect of gallic acid (GA) against cispl...
OBJECTIVE: To determine the effect of cyclophosphamide and cisplatin on ovarian reserve in rats by t...
Background: Cisplatin is a potent antineoplastic agent for many cancers but causes several levels of...
The aim of this study is to evaluate the effects of sildenafil citrate on cisplatin-induced ovarian ...
Introduction: Agents to reduce the gonadotoxic effects of chemotherapeutics are still under investig...
Purpose: This study was aimed to evaluate the protective effect of edaravone on cisplatin-induced ov...
Aim: This study investigated the protective effects of sildenafil (SIL) and resveratrol (RSV) on ova...
WOS: 000343022600014PubMed ID: 25142624Objective: To investigate whether granulocyte-colony stimulat...
Objective: To evaluate the protective effect of GnRH agonist for the prevention of ovarian reserve d...
Background. Apart from the role of progesterone in reproductive physiology, the protective role of e...
PubMed ID: 24959584Cisplatin (CP), an antitumor agent, has been shown to cause ovarian injury and dy...
Sildenafil is the first commercially available selective inhibitor of phosphodiesterase-5 (PDE5) and...
The aim of this study was to investigate the potential therapeutic efficacy of chrysin (CHS) against...
Ovarian damage and fertility impairment are major side effects of chemotherapy in pre-menopausal can...
Copyright © 2014 Oytun Erbas ̧ et al. This is an open access article distributed under the Creative ...
The aim of the present study was to evaluate the protective effect of gallic acid (GA) against cispl...
OBJECTIVE: To determine the effect of cyclophosphamide and cisplatin on ovarian reserve in rats by t...
Background: Cisplatin is a potent antineoplastic agent for many cancers but causes several levels of...